Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
229.03
+1.22 (0.54%)
Apr 26, 2024, 4:00 PM EDT - Market closed
CRL Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 276.77 | 233.91 | 241.21 | 228.42 | 238.01 | 195.44 | 163.79 | 117.63 | 117.95 | 160.02 | Upgrade
|
| Cash & Cash Equivalents | 276.77 | 233.91 | 241.21 | 228.42 | 238.01 | 195.44 | 163.79 | 117.63 | 117.95 | 160.02 | Upgrade
|
| Cash Growth | 18.32% | -3.03% | 5.60% | -4.03% | 21.78% | 19.32% | 39.25% | -0.27% | -26.29% | 2.63% | Upgrade
|
| Receivables | 780.38 | 752.39 | 642.88 | 617.74 | 514.03 | 472.25 | 430.02 | 364.05 | 270.07 | 257.99 | Upgrade
|
| Inventory | 380.26 | 255.81 | 199.15 | 185.7 | 160.66 | 127.89 | 114.96 | 95.83 | 93.74 | 89.04 | Upgrade
|
| Other Current Assets | 171.26 | 196.92 | 190.85 | 169.27 | 108.62 | 102.25 | 117.86 | 79.32 | 77.48 | 72.2 | Upgrade
|
| Total Current Assets | 1,609 | 1,439 | 1,274 | 1,201 | 1,021 | 897.84 | 826.63 | 656.83 | 559.23 | 579.25 | Upgrade
|
| Property, Plant & Equipment | 2,034 | 1,857 | 1,584 | 1,303 | 1,184 | 932.88 | 781.97 | 755.83 | 677.96 | 676.8 | Upgrade
|
| Long-Term Investments | 243.81 | 311.6 | 201.35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Goodwill and Intangibles | 3,959 | 3,805 | 3,773 | 2,597 | 2,230 | 1,858 | 1,175 | 1,182 | 719.63 | 499.95 | Upgrade
|
| Other Long-Term Assets | 349.66 | 189.54 | 191.76 | 390.36 | 257.27 | 167.15 | 146.66 | 117.18 | 111.67 | 114.58 | Upgrade
|
| Total Long-Term Assets | 6,586 | 6,164 | 5,750 | 4,290 | 3,671 | 2,958 | 2,103 | 2,055 | 1,509 | 1,291 | Upgrade
|
| Total Assets | 8,195 | 7,603 | 7,024 | 5,491 | 4,693 | 3,856 | 2,930 | 2,712 | 2,068 | 1,871 | Upgrade
|
| Accounts Payable | 168.94 | 205.92 | 198.13 | 122.48 | 111.5 | 66.25 | 77.84 | 68.49 | 36.68 | 33.82 | Upgrade
|
| Deferred Revenue | 241.82 | 264.26 | 219.7 | 207.94 | 171.81 | 145.14 | 117.57 | 127.73 | 81.34 | 78.12 | Upgrade
|
| Current Debt | 0 | 0 | 0 | 50.21 | 38.55 | 31.42 | 31 | 27.31 | 17.03 | 31.9 | Upgrade
|
| Other Current Liabilities | 644.33 | 621.41 | 615.35 | 459.12 | 388.33 | 315.42 | 237.1 | 206.06 | 176.71 | 150.84 | Upgrade
|
| Total Current Liabilities | 1,055 | 1,092 | 1,033 | 839.75 | 710.18 | 558.22 | 463.5 | 429.59 | 311.76 | 294.69 | Upgrade
|
| Long-Term Debt | 3,066 | 3,097 | 2,917 | 2,085 | 1,966 | 1,637 | 1,114 | 1,208 | 846 | 740.56 | Upgrade
|
| Other Long-Term Liabilities | 414.54 | 390.4 | 482.58 | 422.25 | 350.22 | 322.76 | 288.3 | 220.73 | 145.18 | 130.99 | Upgrade
|
| Total Long-Term Liabilities | 3,481 | 3,488 | 3,399 | 2,507 | 2,316 | 1,959 | 1,402 | 1,428 | 991.17 | 871.55 | Upgrade
|
| Total Liabilities | 4,536 | 4,579 | 4,432 | 3,347 | 3,026 | 2,518 | 1,866 | 1,858 | 1,303 | 1,166 | Upgrade
|
| Total Debt | 3,066 | 3,097 | 2,917 | 2,135 | 2,004 | 1,668 | 1,145 | 1,235 | 863.03 | 772.46 | Upgrade
|
| Debt Growth | -1.00% | 6.20% | 36.58% | 6.53% | 20.17% | 45.66% | -7.28% | 43.10% | 11.72% | 16.37% | Upgrade
|
| Retained Earnings | 1,887 | 1,433 | 980.75 | 625.41 | 280.33 | 42.1 | 288.66 | 165.3 | 10.54 | -138.78 | Upgrade
|
| Comprehensive Income | -196.43 | -262.06 | -164.74 | -138.87 | -178.02 | -172.7 | -144.73 | -253.76 | -135.55 | -74.25 | Upgrade
|
| Shareholders' Equity | 3,597 | 2,976 | 2,535 | 2,115 | 1,635 | 1,317 | 1,045 | 836.77 | 733.07 | 672.2 | Upgrade
|
| Net Cash / Debt | -2,789.61 | -2,863.36 | -2,675.32 | -1,906.96 | -1,766.45 | -1,472.57 | -981.31 | -1,117.38 | -745.08 | -612.44 | Upgrade
|
| Net Cash Per Share | -54.22 | -55.81 | -52.02 | -37.68 | -35.55 | -30.04 | -20.21 | -23.30 | - | - | Upgrade
|
| Working Capital | 553.58 | 347.45 | 240.91 | 361.38 | 311.14 | 339.61 | 363.12 | 227.24 | 247.47 | 284.57 | Upgrade
|
| Book Value Per Share | 70.22 | 58.58 | 50.40 | 42.68 | 33.54 | 27.48 | 22.01 | 17.80 | 15.72 | 14.33 | Upgrade
|